Antibodies Market, By Drug Type (Monoclonal antibodies, Polyclonal antibodies, Antibody-drug complexes (ADCs), by Disease Indication (CNS Disorders, Cardiovascular, Cancer, Autoimmune Disorders, COVID-19, Others) By End User (Hospitals, Long-term Care Facilities, Research institutes), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Apr 2023

Code : CMI2629

Pages :170

Formats :

Excel and PDF

Industry : Biotechnology

Antibodies MarketSize and Trends

The global antibodies market is estimated to be valued at US$ 224,083.5 million in 2023 and is expected to exhibit a CAGR of 12.9% during the forecast period (2023-2030).

Figure 1. Global Antibodies Market Share (%), By Drug Type, 2023

Market Trends

Global Antibodies Market Trends

Market Trends: Key trends Driving Market Growth

Global Antibodies Market: Key Trends

Increasing authorizations for antibodies by the regulatory authorities

Increasing authorizations by the regulatory authorities is expected to drive the global antibodies market over the forecast period. For instance, in May 2021, Roche India, announced that the Central Drugs Standards Control Organization (CDSCO) has provided an Emergency Use Authorization (EUA) for Roche’s antibody cocktail (Casirivimab and Imdevimab) in India.

Figure 2. Global Antibodies Market Value (US$ Million), By Region, 2023

Global Antibodies Market – Market Trends

Increasing authorization for antibodies by the regulatory authorities

Increasing authorizations for antibodies by the regulatory authorities is expected to drive the global antibodies market over the forecast period. For instance, in May 2021, Roche India announced that the Central Drugs Standards Control Organization (CDSCO) has provided an Emergency Use Authorization (EUA) for Roche’s antibody cocktail (Casirivimab and Imdevimab) in India.